News

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.
Snot plays a powerful role in protecting us from disease – and its colour alone can provide insights into what's going on in ...
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent ...
For parents of kids with severe food allergies like mine, the rite of passage that is starting primary school is fraught with very real, very deadly fears that they will come to serious harm – or ...
Atai Life Sciences (NASDAQ:ATAI) is one of the best-performing NASDAQ stocks according to analysts. On July 1, Atai Life ...
Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...
The Salvation Army urges public access to emergency drug-reversal kits as fatalities soar and awareness remains dangerously ...
Jessica Tarlov’s voice is more than just unique; it’s kind, courageous and desperately needed. Trump's attacks are indecent and brutish ...
In Pune, a 22-year-old IT professional was allegedly raped in her flat by a man posing as a courier executive. The assailant ...
This year also brings a shiny new shopping feature: “Today’s Big Deals”—a daily, themed drop of limited-time offers from top ...
Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe ...